-+ 0.00%
-+ 0.00%
-+ 0.00%

Cantor Fitzgerald Maintains Overweight on Teradyne, Raises Price Target to $400

Benzinga·04/09/2026 14:25:29
Listen to the news
Cantor Fitzgerald analyst C.J. Muse maintains Teradyne (NASDAQ:TER) with a Overweight and raises the price target from $330 to $400.